Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma

Table 1

Relationship between CADM1/TSLC1 expression and clinicopathological variables of ESCC.

Variable	CADM1/TSLC1 expression		value
	Positive ()	Negative ()
Age (years)			0.145
<60	128 (54.2%)	37 (64.9%)
≥60	108 (45.8%)	20 (35.1%)
Sex			0.032
Male	171 (72.5%)	33 (57.9%)
Female	65 (27.5%)	24 (42.1%)
Location			0.674
Upper thoracic	25 (10.6%)	4 (7.0%)
Middle thoracic	179 (75.8%)	46 (80.7%)
Lower thoracic	32 (13.6%)	7 (12.3%)
Histological grade			0.000
I	77 (32.6%)	12 (21.1%)
II	145 (61.4%)	18 (31.6%)
III	14 (6.0%)	27 (47.3%)
Depth of invasion			0.791
T1-2	46 (19.5%)	12 (21.1%)
T3-4	190 (80.5%)	45 (78.9%)
Tumor size (cm)			0.410
≤5	165 (70.0%)	43 (75.4%)
>5	71 (30.0%)	14 (24.6%)
Lymph node metastasis			0.997
Positive	116 (49.2%)	28 (49.1%)
Negative	120 (50.8%)	29 (50.9%)
TNM stage			0.905
I-II	118 (50.0%)	28 (49.1%)
III	118 (50.0%)	29 (50.9%)